- Patent Title: Preparation methods for a novel generation of biological safe KLH products used for cancer treatment, for the development of conjugated therapeutic vaccines and as challenging agents
-
Application No.: US15318268Application Date: 2014-06-12
-
Publication No.: US10221220B2Publication Date: 2019-03-05
- Inventor: Ortwin Kottwitz , Thomas Stiefel , Shammana N. Muddukrishna
- Applicant: Biosyn Arzneimittel GmbH
- Applicant Address: DE Fellbach
- Assignee: biosyn Arzneimittel GmbH
- Current Assignee: biosyn Arzneimittel GmbH
- Current Assignee Address: DE Fellbach
- Agency: Leydig, Voit & Mayer, Ltd.
- International Application: PCT/EP2014/062276 WO 20140612
- International Announcement: WO2015/188868 WO 20151217
- Main IPC: A61L2/00
- IPC: A61L2/00 ; C07K1/34 ; C07K14/435
Abstract:
The present invention relates to the provision of a biologically safe hemolymph sera, preferably hemocyanin, more preferably KLH (keyhole limpet hemocyanin). A method for producing virus free hemocyanin is provided.
Public/Granted literature
Information query
IPC分类:
